Breakthrough Chikungunya Vaccine of Valneva’s: Phase 3 trial Data 2 min read News Breakthrough Chikungunya Vaccine of Valneva’s: Phase 3 trial Data The Scientific Reporters June 24, 2023 Valneva, a renowned global market leader in vaccine development, has published the research clinical data of its... Read More Read more about Breakthrough Chikungunya Vaccine of Valneva’s: Phase 3 trial Data
